Anesthetic Considerations In Congenital Diaphragmatic Hernia

Earn CME/CE in your profession:


Continuing Education Activity

Congenital diaphragmatic herniation results in unique pathophysiologic changes that may prove to be a challenge to manage perioperatively. Anesthesiologists involved in the care of these patients must have a thorough understanding of the disease process and know how to evaluate and manage this condition throughout the perioperative period. This activity reviews the principles and considerations for safe anesthetic administration for patients with a congenital diaphragmatic hernia and highlights the role of interprofessional teams in achieving perioperative goals and optimizing outcomes.

Objectives:

  • Review the pathophysiologic changes most pertinent to anesthetic concerns for congenital diaphragmatic hernia.
  • Describe the role of anesthesia during the prenatal and postnatal stages for congenital diaphragmatic hernia.
  • Summarize the preoperative evaluation to be performed prior to undergoing surgical repair for congenital diaphragmatic hernia.
  • Outline the general anesthetic considerations for the intraoperative period for congenital diaphragmatic hernia for the interprofessional team to maximize patient outcomes.

Introduction

Congenital diaphragmatic hernia (CDH) is a rare condition where an incomplete closure of the developing diaphragm results in herniation of the abdominal viscera into the thoracic cavity. The thoracic crowding and increased pressures detrimentally affect the developing cardiopulmonary system. Understanding the pathophysiology, prenatal interventions, postnatal evaluation, and intraoperative considerations is essential to guide perioperative anesthetic care.

An overview of the etiology, epidemiology, diagnosis, and general medical management of CDH is discussed elsewhere.[1]

Issues of Concern

Pathophysiology

Neonates with CDH have several key differences in cardiopulmonary physiology, most notably being poor gas exchange, left ventricular (LV) hypoplasia, right ventricular (RV) hypertrophy, and pulmonary HTN (PH).[2][3] Abdominal viscera compressing the developing lungs interferes with branching of pulmonary airways and pulmonary vasculature, leading to pulmonary hypoplasia and vascular remodeling. The underdeveloped lungs are characterized by poor gas exchange caused primarily by thickened alveolar walls and diminished functional surface area secondary to decreased bronchiolar terminal branching, acinar hypoplasia, and dysfunctional surfactant production.[4] 

PH results from hypertrophy of pulmonary vasculature as well as increased vasoreactivity and is exacerbated by the elevated arterial carbon dioxide (PaCO2) levels and decreased oxygen (PaO2) levels associated with inefficient gas exchange.[5]

The compressive forces of the herniation also have the potential to alter cardiac physiology significantly. LV hypoplasia with associated poor LV function is not an uncommon finding.[6] One likely cause of LV hypoplasia is decreased LV filling pressures due to right-to-left shunting via a patent ductus arteriosus (PDA) in the setting of pulmonary hypertension. Additionally, compressive forces may cause cardiac rotation, favoring blood flow through a patent foramen ovale (PFO), further exacerbating the shunt and decreasing LV preload.[7] By contrast, the right side of the heart more often is found to hypertrophy due to the elevated pulmonary pressures and increased PFO shunting, leading to increases in both afterload and preload, respectively.[8] The combination of significant PH and residual fetal circulatory elements may lead to severe hypoxemia refractory to conventional treatments, a condition known as persistent pulmonary hypertension of the newborn (PPHN).[8]

Additional physiologic concerns may be brought to light upon further evaluation with fetal MRI or echocardiography. Intestinal malrotation and congenital heart disease are both commonly seen in this patient population; CNS, renal, and esophageal abnormalities are rarer but may also occur.[3]

Prenatal Stage and Delivery

Currently, the only prenatal invasive intervention offered is fetal endoluminal tracheal occlusion (FETO) and is generally only performed on fetuses with severe CDH based on observed-to-expected lung-to-head ratio (O/E LHR) scoring and the presence of liver herniation.[9] The procedure involves the percutaneous placement of a balloon in the fetal trachea to prevent expulsion of pulmonary fluid. Blockage of the normal egression of lung fluid during development will increase transpulmonic pressures, helping the fetal lung expand against the herniated viscera. This occlusion is performed around 27 to 29 weeks and is often removed by 34 weeks either through ultrasound-guided puncture of the balloon or fetal tracheoscopic takedown and retrieval.[10]

The occlusion may also be taken down at birth, making use of the ex-utero intrapartum treatment (EXIT) procedure to provide a bridge to intubation.[11] The occlusion is best removed at least one day prior to birth to allow for repopulation of type II pneumocytes, given that tracheal occlusion has been found to reduce these cell numbers.[12] FETO is currently considered experimental, although initial case studies showed increased survival rates after undergoing FETO.[13] Results from the European Tracheal Occlusion to Accelerate Lung Growth (TOTAL) and Fetal Endoscopic Tracheal Occlusion (FETO) clinical trials are currently pending.[3][14]

FETO Anesthetic Considerations

Maternal anesthesia can be achieved either with local, spinal-epidural, or general anesthesia, depending on the clinical situation and comfort level of the patient.[10] Anesthesia for the fetus involves an ultrasound-guided intramuscular injection of fentanyl, rocuronium, and atropine to achieve analgesia and paralysis while mitigating fetal bradycardia.[3] As this procedure will involve significant stress to the fetus, it is routine to measure fetal heart rate by Doppler ultrasound both before and after the operation and should be obtained intraoperatively if there is any concern for fetal deterioration. Maternal mean arterial pressure (MAP) should be maintained within 20% of baseline to ensure adequate uteroplacental blood flow.

Delivery Day

Delivery is planned for 37 to 39 weeks at a tertiary center with extracorporeal membrane oxygenation (ECMO) capabilities.[15] Deliveries can be performed either as spontaneous vaginal or cesarean section. Neonates are intubated at birth, ventilated mechanically, and decompressed via an oro- or nasogastric tube set to low continuous suction. Neonates will continue to receive care in the neonatal intensive care unit (NICU), where they will be medically optimized before repairing the diaphragmatic hernia.

Preoperative Medical Optimization and Evaluation

Preoperative evaluation ensures the patient is adequately optimized and stable for the procedure. The key medical goals for the neonate in preparing for surgery include improving gas exchange in the lungs and oxygen delivery to the periphery, lowering pulmonary arterial pressures to acceptable levels, correcting acid-base imbalances, and addressing any significant comorbidities. Additionally, it is important to ascertain at what point the hernia occurred in gestation, as early herniation is associated with worse pulmonary development and requires greater ventilatory assistance when compared to late herniation.[16]

Pertinent tests and imaging to be performed prior to surgery include a complete blood count, complete metabolic panel, lactate, coagulation assays, arterial blood gas, chest X-ray, echocardiography, and a head ultrasound. The CDH Euro Consortium suggested the following as indicators that the neonate is stable for surgery:[15]

  • Normal MAP for gestation
  • Preductal SpO2 between 85% to 95% on FiO2 < 50%
  • Lactate < 3 mmol/L
  • UOP > 1 cc/kg/hr

An additional consideration for these patients is whether or not they require ECMO for increased support. Common indications for ECMO include hypoxemia, hypoxia, or metabolic acidosis that is refractory to medical therapy and ventilator management. ECMO exclusion criteria may include lethal chromosomal abnormalities or severe intracranial hemorrhage.[17] Transitioning to ECMO should be considered if any of the following conditions persist refractory to medical treatment:[17][18]

  • Preductal SpO2 < 85% or postductal SpO2 < 70%
  • PaO2 < 40 mm Hg
  • Mixed venous saturation < 60%
  • Oxygenation index > 40 for at least 3 hours
  • Mixed acidosis pH < 7.2 with hemodynamic instability
  • Requiring PIP > 28 cmH2O or MAwP > 15 cmH2O to maintain oxygenation
  • Lactate > 5 mmol/L with a pH < 7.2
  • Hypotension refractory to fluids and pressors
  • Severe air leak and requiring high ventilatory settings

*PIP = peak inspiratory pressure; MAwP = mean airway pressure; FiO2 = fraction of inspired oxygen; oxygenation index = MAwP x FiO2 x 100 ÷ PaO2.

Hernia Repair

Delaying surgery until the patient is medically optimized has been shown to improve patients’ outcomes, although the timing of surgery is debated for patients on ECMO. Some centers prefer early repair on ECMO, while others delay surgery until the neonate has successfully been weaned off circulatory support.[3]

Options for diaphragmatic surgical repair following hernia reduction include primary closure, synthetic patch repair, or an abdominal wall muscle flap repair.[19] Closures by patch or muscle flap are reserved for large defects that would require too much tension for primary closure. The repair is performed either thoracoscopically or open. Thoracoscopic repairs have similar survival rates to open procedures but have been associated with higher levels of PaCO2 and acidosis secondary to CO2 insufflation.[20]

General Anesthetic Approach

Patients are often intubated while in the NICU prior to transfer to the operating room (OR); for those who require intubation in the OR, it is recommended to do rapid-sequence intubation with propofol. Mask ventilation should be avoided, given the risk of gastric insufflation. Neuromuscular blocking agents (NMBAs) should generally be avoided for intubation as there is evidence of lung function deterioration with administration without any apparent added benefit.[21]

An arterial line is essential for intraoperative monitoring and is preferentially placed in the right radial artery to provide preductal measurements. Venous access is best obtained in the upper extremities as the reduction of herniated viscera will increase abdominal compartment pressures, potentially decreasing the flow of the inferior vena cava. Central lines may be helpful as they can be used postoperatively to administer vasoactive medications. A naso or orogastric tube should be in place and set to low continuous suction for gastric decompression.

Anesthesia is maintained primarily through high-dose intravenous (IV) opioids. Volatile anesthetics can be used as a supplement. However, these agents should be given cautiously to avoid compromising cardiac output. Nitrous oxide use is avoided, given the risk of expansion within the thoracic cavity or herniated viscera. As with intubation, NMBAs are not recommended given decreased lung compliance from the loss of spontaneous ventilation.[21]

Intraoperative Monitoring

Monitoring should include pre and postductal pulse oximetry, an arterial line, and the standard monitors for heart rate, noninvasive blood pressure (BP) cuff, temperature, end-tidal CO2, and a three- or five-lead EKG. An increase in the difference between pre and postductal saturations may indicate worsening pulmonary hypertension, causing an associated increase of the right-to-left PDA shunt. The arterial line is needed for invasive BP monitoring and arterial blood gas analysis (ABG). Labs to monitor include hemoglobin/hematocrit, glucose, and ABGs. It is also important to regularly monitor the nonoperative lung field for evidence of pneumothorax as this may occur secondary to excessive ventilatory pressures.[3]

Ventilation

Ventilation goals are similar to clinical stability indicators as above. Ventilator optimization strives to ensure adequate oxygenation and ventilation while avoiding barotrauma. This is accomplished by using permissive hypercapnia, careful monitoring of PIP, and high-frequency oscillatory ventilation when CMV fails. While respiratory alkalosis from hyperventilation would decrease pulmonary hypertension and reduce shunting via the PDA, it carries an increased risk of barotrauma. Excessive ventilatory pressures increase the risk of incurring a contralateral pneumothorax. General goals for ventilation include the following:[15][22]

  • Preductal SpO2 between 85% to 95%
  • Postductal SpO2 > 70%
  • PIP < 25 cmH2O with a PEEP set between 3 to 5 cmH2O
  • FiO2 < 50%, titrated to preductal SpO2 goals
  • Respiratory rate between 40 to 60 breaths per minute
  • PaCO2 between 50 to 70 mm Hg
  • the pH of 7.25 and above

*PEEP = positive end-expiratory pressure

Cardiovascular

Hemodynamic goals are to maintain adequate cardiac output and blood pressure through the use of inotropes, vasopressors, and fluids. Target blood pressure ranges should be based on the neonate’s gestational age. Most patients with CDH have concomitant adrenal insufficiency based on low random cortisol measurements; hypotension in this population generally responds well to stress-dose hydrocortisone. However, long-term administration of steroids has been found to increase the risk of mortality and sepsis.[23][24] Fluid boluses of 10 to 20 cc/kg are also appropriate if the patient is hypovolemic. Dextrose-rich maintenance fluids are given for caloric and hemodynamic requirements but should be monitored carefully to not compromise cardiac function. 

Pulmonary Hypertension

Pulmonary hypertension is often prominent among this patient population. Commonly used medications include inhaled nitric oxide (iNO) and milrinone. Pulmonary vasodilatory therapy should not be started routinely on all patients but rather reserved for those with signs of poor organ perfusion with preductal SpO2 < 85% or a difference between pre and postductal SpO2 readings greater than 10%.[25]

If requiring PH treatment, iNO can be initiated for those patients with a normal functioning LV, whereas milrinone may be more appropriate for those neonates with comorbid LV diastolic dysfunction.[2] Milrinone in this setting can additionally act as a lusitrope to increase LV filling and reduce the left-to-right shunt via the PFO. If no response is seen with these agents, then a second-line agent may be administered instead, such as a prostacyclin or a phosphodiesterase inhibitor.

Postoperative Management

While in the post-anesthesia care unit, the patient will need continued hemodynamic monitoring and supportive care. Lung fields should be regularly assessed for any evidence of pneumothorax, hemorrhage, or atelectasis. Postoperative care will continue in the NICU with the patient intubated and mechanically ventilated. Ventilatory and hemodynamic support is weaned as tolerated. A multimodal pain regimen may include opioids, an epidural, and acetaminophen if liver function tests are normal. Monitoring for return of bowel function and initiating enteral feeding as tolerated is encouraged for optimal postoperative recovery.

Clinical Significance

Caring for patients with CDH is both rewarding and oftentimes complex. The perioperative management of these patients relies significantly on understanding the underlying physiology, experimental evidence, and expert consensus.

The major goals for these patients involve identifying the unique anatomic and physiologic changes through perinatal work-up, enhancing prenatal pulmonary development, stabilizing and optimizing medically after delivery, and safely repairing the diaphragmatic defect under general anesthesia. During the prenatal stage, the anesthesia team can provide maternal and fetal anesthesia to enable successful occlusion of the trachea for those patients undergoing FETO.

Preoperatively, the role of the team is to ensure the neonate is sufficiently stable to tolerate the anesthesia and stress of surgery. For the diaphragmatic repair, the anesthesiologist provides anesthesia and analgesia for the infant while monitoring clinical stability and assessing potential complications. The key intraoperative focuses are ensuring hemodynamic stability, managing PH as needed, and avoiding pulmonary barotrauma through ventilator optimization.

Enhancing Healthcare Team Outcomes

Patients diagnosed with CDH have complex needs that require the services of multiple hospital teams to provide optimal treatment and support. Managing the perioperative care of these patients involves extensive cooperation between the interprofessional team members. The anesthesia team coordinates closely with the neonatologist ICU team, pediatric surgery team, and maternal-fetal medicine team regarding medical management and timing of the procedures.

Maintaining open and consistent communication with the surgical and ICU teams is key to ensuring the neonate’s medical condition is fully optimized and the likelihood of a successful procedure is maximized. Many other professional teams also take important roles in caring for these patients, including ICU nursing staff, respiratory therapists, geneticists, other physician specialists, developmental psychologists, social workers, and other allied health professionals.  

A cohesive interprofessional team can effectively achieve high-quality medical care for these infants and provide a source of comfort and confidence for the parents of the neonates. Navigating each of the steps from prenatal care through postoperative management can be very challenging. During this time, the interprofessional teams must provide a unified approach towards caring for these infants and communicate that plan clearly to the parents.


Article Details

Article Author

Kurt Leininger

Article Editor:

Katherine Chiu

Updated:

6/29/2021 9:42:40 AM

References

[1]

Dumpa V,Chandrasekharan P, Congenital Diaphragmatic Hernia StatPearls. 2021 Jan;     [PubMed PMID: 32310536]

[2]

Kinsella JP,Steinhorn RH,Mullen MP,Hopper RK,Keller RL,Ivy DD,Austin ED,Krishnan US,Rosenzweig EB,Fineman JR,Everett AD,Hanna BD,Humpl T,Raj JU,Abman SH,Pediatric Pulmonary Hypertension Network (PPHNet)., The Left Ventricle in Congenital Diaphragmatic Hernia: Implications for the Management of Pulmonary Hypertension. The Journal of pediatrics. 2018 Jun;     [PubMed PMID: 29628412]

[3]

Chatterjee D,Ing RJ,Gien J, Update on Congenital Diaphragmatic Hernia. Anesthesia and analgesia. 2020 Sep;     [PubMed PMID: 31335403]

[4]

George DK,Cooney TP,Chiu BK,Thurlbeck WM, Hypoplasia and immaturity of the terminal lung unit (acinus) in congenital diaphragmatic hernia. The American review of respiratory disease. 1987 Oct;     [PubMed PMID: 3662245]

[5]

Pierro M,Thébaud B, Understanding and treating pulmonary hypertension in congenital diaphragmatic hernia. Seminars in fetal     [PubMed PMID: 25456753]

[6]

Siebert JR,Haas JE,Beckwith JB, Left ventricular hypoplasia in congenital diaphragmatic hernia. Journal of pediatric surgery. 1984 Oct;     [PubMed PMID: 6502429]

[7]

Stressig R,Fimmers R,Eising K,Gembruch U,Kohl T, Preferential streaming of the ductus venosus and inferior caval vein towards the right heart is associated with left heart underdevelopment in human fetuses with left-sided diaphragmatic hernia. Heart (British Cardiac Society). 2010 Oct;     [PubMed PMID: 20702536]

[8]

Chandrasekharan PK,Rawat M,Madappa R,Rothstein DH,Lakshminrusimha S, Congenital Diaphragmatic hernia - a review. Maternal health, neonatology and perinatology. 2017;     [PubMed PMID: 28331629]

[9]

Deprest J,Brady P,Nicolaides K,Benachi A,Berg C,Vermeesch J,Gardener G,Gratacos E, Prenatal management of the fetus with isolated congenital diaphragmatic hernia in the era of the TOTAL trial. Seminars in fetal     [PubMed PMID: 25447987]

[10]

Harrison MR,Adzick NS,Longaker MT,Goldberg JD,Rosen MA,Filly RA,Evans MI,Golbus MS, Successful repair in utero of a fetal diaphragmatic hernia after removal of herniated viscera from the left thorax. The New England journal of medicine. 1990 May 31;     [PubMed PMID: 2336088]

[11]

Ruano R,Yoshisaki CT,da Silva MM,Ceccon ME,Grasi MS,Tannuri U,Zugaib M, A randomized controlled trial of fetal endoscopic tracheal occlusion versus postnatal management of severe isolated congenital diaphragmatic hernia. Ultrasound in obstetrics     [PubMed PMID: 22170862]

[12]

De Paepe ME,Papadakis K,Johnson BD,Luks FI, Fate of the type II pneumocyte following tracheal occlusion in utero: a time-course study in fetal sheep. Virchows Archiv : an international journal of pathology. 1998 Jan;     [PubMed PMID: 9463582]

[13]

DeKoninck P,Gomez O,Sandaite I,Richter J,Nawapun K,Eerdekens A,Ramirez JC,Claus F,Gratacos E,Deprest J, Right-sided congenital diaphragmatic hernia in a decade of fetal surgery. BJOG : an international journal of obstetrics and gynaecology. 2015 Jun;     [PubMed PMID: 25227954]

[14]

Deprest JA,Hyett JA,Flake AW,Nicolaides K,Gratacos E, Current controversies in prenatal diagnosis 4: Should fetal surgery be done in all cases of severe diaphragmatic hernia? Prenatal diagnosis. 2009 Jan;     [PubMed PMID: 19125386]

[15]

Snoek KG,Reiss IK,Greenough A,Capolupo I,Urlesberger B,Wessel L,Storme L,Deprest J,Schaible T,van Heijst A,Tibboel D,CDH EURO Consortium., Standardized Postnatal Management of Infants with Congenital Diaphragmatic Hernia in Europe: The CDH EURO Consortium Consensus - 2015 Update. Neonatology. 2016;     [PubMed PMID: 27077664]

[16]

Chang SW,Lee HC,Yeung CY,Chan WT,Hsu CH,Kao HA,Hung HY,Chang JH,Sheu JC,Wang NL, A twenty-year review of early and late-presenting congenital Bochdalek diaphragmatic hernia: are they different clinical spectra? Pediatrics and neonatology. 2010 Feb;     [PubMed PMID: 20225535]

[17]

McHoney M,Hammond P, Role of ECMO in congenital diaphragmatic hernia. Archives of disease in childhood. Fetal and neonatal edition. 2018 Mar;     [PubMed PMID: 29138242]

[18]

Delaplain PT,Jancelewicz T,Di Nardo M,Zhang L,Yu PT,Cleary JP,Morini F,Harting MT,Nguyen DV,Guner YS,Study by ELSO CDH Interest Group., Management preferences in ECMO mode for congenital diaphragmatic hernia. Journal of pediatric surgery. 2019 May;     [PubMed PMID: 30786989]

[19]

Barnhart DC,Jacques E,Scaife ER,Yoder BA,Meyers RL,Harman A,Downey EC,Rollins MD, Split abdominal wall muscle flap repair vs patch repair of large congenital diaphragmatic hernias. Journal of pediatric surgery. 2012 Jan;     [PubMed PMID: 22244397]

[20]

Liem NT,Nhat LQ,Tuan TM,Dung le A,Ung NQ,Dien TM, Thoracoscopic repair for congenital diaphragmatic hernia: experience with 139 cases. Journal of laparoendoscopic     [PubMed PMID: 21204646]

[21]

Murthy V,D'Costa W,Nicolaides K,Davenport M,Fox G,Milner AD,Campbell M,Greenough A, Neuromuscular blockade and lung function during resuscitation of infants with congenital diaphragmatic hernia. Neonatology. 2013;     [PubMed PMID: 23182955]

[22]

Logan JW,Rice HE,Goldberg RN,Cotten CM, Congenital diaphragmatic hernia: a systematic review and summary of best-evidence practice strategies. Journal of perinatology : official journal of the California Perinatal Association. 2007 Sep;     [PubMed PMID: 17637787]

[23]

Kamath BD,Fashaw L,Kinsella JP, Adrenal insufficiency in newborns with congenital diaphragmatic hernia. The Journal of pediatrics. 2010 Mar;     [PubMed PMID: 20056240]

[24]

Robertson JO,Criss CN,Hsieh LB,Matsuko N,Gish JS,Mon RA,Johnson KN,Gadepalli SK, Steroid use for refractory hypotension in congenital diaphragmatic hernia. Pediatric surgery international. 2017 Sep;     [PubMed PMID: 28685301]

[25]

Barrington KJ,Finer N,Pennaforte T,Altit G, Nitric oxide for respiratory failure in infants born at or near term. The Cochrane database of systematic reviews. 2017 Jan 5;     [PubMed PMID: 28056166]